 Morphic Holding Inc NASDAQ: MORF, Athenex Inc NASDAQ: ATNX and Lixte Biotechnology Holdings Inc NASDAQ: LIXT are among the healthcare movers on Monday. Morphic Jumps On Data: Morphic, a biopharma developing oral integrin therapies for treating chronic diseases, reported positive Phase 1 data for its MORF-057, which is being evaluated for inflammatory bowel disease. 